Kim BH, Yu SJ, Kang W, Cho SB, et al. Expert Consensus on the Management of Adverse Events in Patients Receiving Lenvatinib for Hepatocellular Carcinoma. J Gastroenterol Hepatol 2021 Nov 1. doi: 10.1111/jgh.15727.
PMID: 34725855